...
首页> 外文期刊>Clinical proteomics. >Unique and differential protein signatures within the mononuclear cells of HIV-1 and hcv mono-infected and co-infected patients
【24h】

Unique and differential protein signatures within the mononuclear cells of HIV-1 and hcv mono-infected and co-infected patients

机译:HIV-1和HCV单感染和共感染患者单核细胞内独特和微分的蛋白质签名

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Pathogenesis of liver damage in patients with HIV and HCV co-infection is complex and multifactorial. Although global awareness regarding HIV-1/HCV co-infection is increasing little is known about the pathophysiology that mediates the rapid progression to hepatic disease in the co-infected individuals. Results: In this study, we investigated the proteome profiles of peripheral blood mononuclear cells from HIV-1 mono-, HCV mono-, and HIV-1/HCV co-infected patients. The results of high-resolution 2D gel electrophoresis and PD quest software quantitative analysis revealed that several proteins were differentially expressed in HIV-1, HCV, and HIV-1/HCV coinfection. Liquid chromatography-mass spectrometry and Mascot database matching (LC-MS/MS analysis) successfully identified 29 unique and differentially expressed proteins. These included cytoskeletal proteins (tropomyosin, gelsolin, DYPLSL3, DYPLSL4 and profilin-1), chaperones and co-chaperones (HSP90-beta and stress-induced phosphoprotein), metabolic and pre-apoptotic proteins (guanosine triphosphate [GTP]-binding nuclear protein Ran, the detoxifying enzyme glutathione S-transferase (GST) and Rho GDP-dissociation inhibitor (Rho-GDI), proteins involved in cell prosurvival mechanism, and those involved in matrix synthesis (collagen binding protein 2 [CBP2]). The six most significant and relevant proteins were further validated in a group of mono- And co-infected patients (n = 20) at the transcriptional levels. Conclusions: The specific pro- And anti- Apoptotic protein signatures revealed in this study could facilitate the understanding of apoptotic and protective immune-mediated mechanisms underlying HIV-1 and HCV co-infection and their implications on liver disease progression in co-infected patients.
机译:背景:HIV和HCV共感染患者肝损伤的发病机制是复杂的和多重的。虽然关于HIV-1 / HCV的全球意识越来越几乎是关于培养了肝病在共感染的个体中快速进展的病理生理学而越来越少的。结果:在本研究中,我们研究了来自HIV-1单,HCV单核和HIV-1 / HCV共感染患者外周血单核细胞的蛋白质组谱。高分辨率2D凝胶电泳的结果和PD Quest软件的定量分析显示,在HIV-1,HCV和HIV-1 / HCV辛切入中差异表达了几种蛋白质。液相色谱 - 质谱和吉祥物数据库匹配(LC-MS / MS分析)成功鉴定了29个独特且差异表达的蛋白质。这些包括细胞骨架蛋白(Trophomyosin,露珠松,DYPL3,DYPLSL4和PREMILIN-1),伴侣和共伴侣(HSP90-β和应力诱导的磷蛋白),代谢和预凋亡蛋白(鸟苷类三磷酸(鸟嘌呤) - 粘连核蛋白质RAN,解毒酶谷胱甘肽S-转移酶(GST)和RHO GDP-解离抑制剂(RHO-GDI),参与细胞刺激机制的蛋白质,以及参与基质合成的人(胶原结合蛋白2 [CBP2])。最多六个在转录水平的一组单次和共感染患者(n = 20)中进一步验证了显着和相关蛋白质。结论:本研究中揭示的具体促进和抗凋亡蛋白签名可以促进对凋亡的理解和保护性免疫介导的机制,HIV-1和HCV共感染的基础及其对肝病进展的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号